Hospital Corporation of America

The vertical mega merger is unveiled as the formula for the future: a new combination of business partners designed for a changing era in healthcare and payer concerns about hospital costs: a way to p

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy transactions that occurred between Sept.23-30. Deal Wat

SYDNEY – Australia’s second-largest hospital operator, Healthscope , could be poised to return to the country’s stock market by July, in a possible AU $4 billion ($3.7 billion) initial public offerin